What is the current stock price of NuGen Medical Devices Inc. (NGMDF)?

As of the latest market data, NuGen Medical Devices Inc. (NGMDF) is trading at $0.01. The stock has seen a loss of -2.31% today.

Does NuGen Medical Devices Inc. (NGMDF) pay a dividend?

Based on current data, NuGen Medical Devices Inc. does not have a confirmed active dividend policy.

What is the market cap of NuGen Medical Devices Inc.?

The current market capitalization of NuGen Medical Devices Inc. (NGMDF) is approximately unavailable.

NGMDF

NuGen Medical Devices Inc.·Healthcare

0.01

2.308%(−0.00)

Market Closed

0.01

13.386%(+0.00)

After Hours

Last Updated: — ET

52W L: $0.0052W H: $0.07

NGMDF NEWS

newsfilecorp.com

Mar 25

NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology

Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering a Ready-to-Fill (RTF) COP/COC injection nozzle designed specifically for pharmaceutical needle-free applications. The nozzle, which is the subject of a newly filed patent application, represents a novel pharmaceutical packaging component that enables needle-free injection using established aseptic fill-finish processes, analogous to prefilled syringes but without a needle.

newsfilecorp.com

Feb 5

NuGen Medical Devices Inc. Provides Update on Health Canada License

Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse of its license with Health Canada. The Company's Health Canada Licence became expired due to an untimely certificate renewal.

newsfilecorp.com

Jan 30

NuGen Medical Devices Inc. Announces CFO Transition

Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, announces that Veronique Laberge has resigned from her position as Chief Financial Officer and Corporate Secretary. Her resignation is effective January 31, 2026.

newsfilecorp.com

Jan 16

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is providing a summary of key developments achieved during 2025 across its Research and Development programs, technical capabilities, clinical initiatives, and global commercial activities. 2025 Operational Highlights Research & Development Demonstrated feasibility of the Ready-to-Fill Nozzle, (a component used in sterile, ready-to-use pharmaceutical filling systems designed to support prefilled drug formats), supporting development of a prefilled solution targeted for future integration.

Company Profile

NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventional/pediatric vaccines. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

2022-02-25

Beta

1.57

Websitewww.nugenmd.com↗